Eydelman Mikhail
SEC CIK 1918033 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | SVP, Gen Counsel, Corp Sec | 41.7K | — | $6.10M | 49 | 2022-06-07 | 2025-03-05 |
Most active insiders at PCVX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PICKERING GRANT | CEO, Dir | — | $3.63M |
| 2 | GUGGENHIME ANDREW | Pres AND CFO | — | $1.64M |
| 3 | Wassil Jim | EVP, COO, Chief Scientific Ofc | — | $1.43M |
| 4 | Dhaliwal Harpreet S. | Chief Technical Ops Off | — | $1.39M |
| 5 | Cowan Elvia | SVP, Fin | — | $988.6K |
| 6 | Jodar Luis | Chief Medical Off | — | — |
| 7 | Lee Jacks | Dir | — | — |
| 8 | Loxam Teri | Dir | — | — |
| 9 | Furey John | Dir | — | — |
| 10 | Paya Carlos V | Dir | — | — |
Eydelman Mikhail made no open-market trades at PCVX in the last 12 months.
Transactions 49
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-07 | 2025-03-05 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $70.74 | -5,000 | 41.7K | -11% | -$353.7K |
| D | 2025-03-07 | 2025-03-05 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +5,000 | 46.6K | +12% | +$107.0K |
| D | 2025-03-03 | 2025-02-27 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | A - Grant | $0.00 | +14.5K | 42.7K | +51% | $0 |
| DM | 2025-03-03 | 2025-02-28+ | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | F - Tax | $72.50 | -1,086 | 41.6K | -3% | -$78.7K |
| DM | 2025-02-07 | 2025-02-05 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $90.07 | -5,000 | 30.3K | -14% | -$450.4K |
| D | 2025-02-07 | 2025-02-05 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +5,000 | 33.2K | +18% | +$107.0K |
| DM | 2025-01-07 | 2025-01-06 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $85.58 | -5,000 | 28.2K | -15% | -$427.9K |
| D | 2025-01-07 | 2025-01-06 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +5,000 | 33.2K | +18% | +$107.0K |
| D | 2024-12-09 | 2024-12-09 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | F - Tax | $92.06 | -475 | 28.2K | -2% | -$43.7K |
| DM | 2024-12-09 | 2024-12-05 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $91.48 | -5,000 | 32.3K | -13% | -$457.4K |
| D | 2024-12-09 | 2024-12-05 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | G - Gift | $0.00 | -110 | 28.7K | -0.4% | $0 |
| D | 2024-12-09 | 2024-12-05 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +5,000 | 33.7K | +17% | +$107.0K |
| DM | 2024-11-06 | 2024-11-05 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $106.36 | -5,000 | 28.6K | -15% | -$531.8K |
| D | 2024-11-06 | 2024-11-05 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +5,000 | 33.6K | +17% | +$107.0K |
| DM | 2024-10-08 | 2024-10-07 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $109.27 | -5,000 | 28.7K | -15% | -$546.4K |
| D | 2024-10-08 | 2024-10-07 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +5,000 | 33.6K | +17% | +$107.0K |
| D | 2024-10-03 | 2024-10-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +5,500 | 34.1K | +19% | +$117.8K |
| DM | 2024-10-03 | 2024-10-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $114.24 | -5,500 | 32.7K | -14% | -$628.3K |
| DM | 2024-09-05 | 2024-09-03 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $112.11 | -1,667 | 30.9K | -5% | -$186.9K |
| D | 2024-09-05 | 2024-09-03 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | F - Tax | $110.15 | -2,203 | 28.6K | -7% | -$242.7K |
| D | 2024-09-05 | 2024-09-03 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +1,667 | 32.5K | +5% | +$35.7K |
| DM | 2024-08-05 | 2024-08-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $78.85 | -1,667 | 31.0K | -5% | -$131.5K |
| D | 2024-08-05 | 2024-08-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +1,667 | 32.5K | +5% | +$35.7K |
| DM | 2024-07-02 | 2024-07-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $76.37 | -1,667 | 31.6K | -5% | -$127.3K |
| D | 2024-07-02 | 2024-07-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +1,667 | 32.5K | +5% | +$35.7K |
| 2024-06-10 | 2024-06-07 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | F - Tax | $70.97 | -335 | 30.8K | -1% | -$23.8K | |
| D | 2024-06-05 | 2024-06-03 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +1,667 | 32.8K | +5% | +$35.7K |
| DM | 2024-06-05 | 2024-06-03 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $72.06 | -1,667 | 31.2K | -5% | -$120.1K |
| DM | 2024-05-03 | 2024-05-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $61.74 | -1,667 | 31.3K | -5% | -$102.9K |
| D | 2024-05-03 | 2024-05-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +1,667 | 32.3K | +5% | +$35.7K |
| DM | 2024-04-03 | 2024-04-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $66.72 | -1,667 | 30.6K | -5% | -$111.2K |
| D | 2024-04-03 | 2024-04-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +1,667 | 32.3K | +5% | +$35.7K |
| D | 2024-03-04 | 2024-03-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +1,667 | 32.9K | +5% | +$35.7K |
| DM | 2024-03-04 | 2024-03-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $73.73 | -1,667 | 31.7K | -5% | -$122.9K |
| D | 2024-03-04 | 2024-03-02 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | F - Tax | $71.55 | -613 | 30.6K | -2% | -$43.9K |
| D | 2024-03-04 | 2024-02-29 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | A - Grant | $0.00 | +10.5K | 31.2K | +51% | $0 |
| DM | 2024-02-05 | 2024-02-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $73.87 | -1,667 | 22.2K | -7% | -$123.1K |
| D | 2024-02-05 | 2024-02-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +1,667 | 22.4K | +8% | +$35.7K |
| DM | 2024-01-04 | 2024-01-02 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | S - Sale+OE | $63.93 | -1,667 | 21.6K | -7% | -$106.6K |
| D | 2024-01-04 | 2024-01-02 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | M - OptEx | $21.41 | +1,667 | 22.4K | +8% | +$35.7K |
| D | 2023-12-11 | 2023-12-07 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | M - OptEx | $21.41 | +10.0K | 31.0K | +48% | +$214.1K |
| D | 2023-12-11 | 2023-12-07 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | F - Tax | $56.78 | -325 | 20.7K | -2% | -$18.5K |
| D | 2023-12-11 | 2023-12-07 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | S - Sale+OE | $56.50 | -10.0K | 21.0K | -32% | -$565.0K |
| DM | 2023-10-04 | 2023-10-02 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | S - Sale+OE | $50.40 | -20.0K | 32.5K | -38% | -$1.01M |
| D | 2023-10-04 | 2023-10-02 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | M - OptEx | $21.41 | +20.0K | 40.5K | +98% | +$428.2K |
| 2023-09-06 | 2023-09-05 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | F - Tax | $51.00 | -1,189 | 20.5K | -5% | -$60.6K | |
| 2023-06-09 | 2023-06-07 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | F - Tax | $51.25 | -645 | 21.7K | -3% | -$33.1K | |
| D | 2023-03-03 | 2023-03-01 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | A - Grant | $0.00 | +13.8K | 21.8K | +171% | $0 |
| 2022-06-09 | 2022-06-07 | PCVX | Vaxcyte, Inc. | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | A - Grant | $0.00 | +7,500 | 7,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations